LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: “NXGL”) announced that its subsidiary, CG Converting and Packaging, has executed a supply agreement with AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company to be a supplier of gel pads to be used with AbbVie’s Rapid Acoustic Pulse device being investigated for improvement in the appearance of cellulite.
Leveraging NEXGEL’s proprietary hydrogel technology, its gel pads will be an important component of the body contouring device.
“We are honored and excited that a company of AbbVie’s stature and reputation has selected our gel pad for use with their product,” stated Adam Levy, CEO at NEXGEL.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.